Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Alpha Emitter Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global alpha emitter market size reached US$ 757.01 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 4,523.77 Million by 2027, exhibiting a growth rate (CAGR) of 31.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global alpha emitter market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type of radionuclide, medical application and end user.

Breakup by Type of Radionuclide:

  • Astatine
  • Radium
  • Actinium
  • Lead
  • Bismuth
  • Others
     

Breakup by Medical Application:

  • Prostate Cancer
  • Bone Metastasis
  • Ovarian Cancer
  • Pancreatic Cancer
  • Endocrine Tumors
  • Others
     

Breakup by End User:

  • Hospitals
  • Medical Research Institutions
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Type of Radionuclide, Medical Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global alpha emitter market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global alpha emitter market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type of radionuclide?
  • What is the breakup of the market based on the medical application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global alpha emitter market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Alpha Emitter Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type of Radionuclide
    6.1    Astatine 
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Radium 
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Actinium 
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Lead 
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Bismuth 
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Medical Application
    7.1    Prostate Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Bone Metastasis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Ovarian Cancer
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pancreatic Cancer
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Endocrine Tumors
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Medical Research Institutions
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Actinium Pharmaceuticals Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Alpha Tau Medical Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Bayer AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Fusion Pharmaceuticals
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    IBA RadioPharma Solutions
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    RadioMedix Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio

List of Figures

Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
Figure 2: Global: Alpha Emitter Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2021
Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2021
Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2021
Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2021
Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: North America: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: United States: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: China: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: India: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: France: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2021
Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million US$), 2022-2027
Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million US$), 2022-2027
Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Alpha Emitter Market: Competitive Structure
Table 7: Global: Alpha Emitter Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4